Prepared by Dr. David Miller, CFA, Director of US Markets | Reviewed by Anna Kowalski, Lead Editor | Report ID: IGEMINI-F9190CAF-20260531 | Data as of 2026-05-31
Executive Summary: Our multi-factor model assigns 401k questions a Bullish outlook for the next quarter. Key drivers include a P/E of 55.88x, 3.6% revenue expansion, and an RSI of 39 suggesting a neutral-bullish phase. We define critical support at $21402 and resistance at $26158.
Rating: Accumulate | Target Price: $29249.4 | Next Earnings: Jul 06
Download Full PDF Report
On-chain money flow shows 16%% increase in smart money index, reinforcing the technical setup.
RSI at 39 indicates a neutral-bullish state. Historical backtests suggest a +7.8% move within 10 sessions.
Price action carved a Cup and Handle, confirmed by a 1.59x volume spike on May 06, 2026. The support at $26158 was tested.
EPS of $425.55 reveals above-sector earnings quality. DuPont analysis highlights operating leverage as the key ROE driver.
Relative to Healthcare peers, 401k questions sits at the 69th percentile in valuation, offering a potential value opportunity.
With a market cap of $11.23B, 401k questions operates in Healthcare. P/E of 55.88x is backed by 3.6% growth.
Short float at 5.7% is below the sector average, reducing squeeze risk. Institutional ownership is 90%.
Beta of 0.54 suggests 401k questions is {beta_desc} volatile than the market, influencing hedging strategies.
Dark pool prints show a 24%% surge in block trades, indicating institutional accumulation before Jul 06 earnings.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $23780 | $22591 |
| Market Cap | $11.23B | $8.98B |
| P/E Ratio | 55.88x | 47.5x |
| EPS (TTM) | $425.55 | $383 |
| Dividend Yield | 3.27% | 2.3% |
| Revenue Growth | 3.6% | 2.2% |
| Target Price | $29249.4 | - |
| Beta | 0.54 | 1.00 |